key: cord-0856544-9yn8o5q6
authors: Okpala, OgoChukwu Vincent; Dim, Cyril Chukwudi; Ugwu, Chukwuebuka Immanuel; Onyemaechi, Simeon; Uchebo, Obiageli; Chukwulobelu, Ugochukwu; Emembolu, Chuma; Okoye, Ben; Igboekwu, Chukwumuanya; Okoye, Uchenna Benedict; Dike, Nelly Chibuzor; Odumegwu, Anastasia Obiageli; Ideh, Christopher; Okoye, Ngozi Christiana; Okpala, Vincent Chinedu; Okoye, Peter Ikenna; Enike, Maryann Chinyere; Onyedikachi, Oluchi
title: Population seroprevalence of SARS-CoV-2 antibodies in Anambra state, South-East, Nigeria
date: 2021-07-19
journal: Int J Infect Dis
DOI: 10.1016/j.ijid.2021.07.040
sha: 53eca372894110fdc96fd97e380a4a93918737a6
doc_id: 856544
cord_uid: 9yn8o5q6

OBJECTIVE: The objective of this study was to determine the proportion of Anambra State population that had been infected by the SARS-CoV-2 virus and developed antibodies before the second wave. METHODS: The WHO-recommended health facility-based cross-sectional approach was adapted for this survey. Between 8(th) and 15(th) December 2020, 3142 participants across the 21 local government areas (LGAs) of the state, aged one year and over, attending randomly selected health facilities were recruited. Demographic and symptom-related information were collected from the participants as well as peripheral whole blood, which was tested for SARS-CoV-2 IgG and IgM with rapid test kits. RESULTS: 425 participants tested positive for IgG only, 74 for IgM only while 54 were positive for both IgG and IgM. Overall, 553 positives were recorded giving a crude seroprevalence of 17(.)6% (95% CI = 16(.)26 – 18(.)98). It ranged widely from 31(.)9% (95% CI = 24(.)43 – 40(.)22) in Onitsha north LGA to 5(.)4% (95% CI = 2(.)19 – 10(.)78) in Awka north. Bayesian Adjustments yielded a state seroprevalence of 16(.)1%. CONCLUSION: One in six residents of the state had been infected by SARS-CoV-2 and developed antibodies before the second wave. All LGAs, age groups, sexes, and settlement types were affected by COVID-19. A large proportion of the population remained susceptible to SARS-CoV-2.

health emergency of international concern (PHEIC) on the 30 th of January 2020 (Eurosurveillance Editorial Team, 2020) . About a month later, on the 27 th of February 2020, Nigeria diagnosed her first case of the coronavirus disease 2019 Nigeria, in mid-December 2020 announced the existence of COVID-19 second wave in the country (Nigeria Centre for Disease Control, 2020c) . Before the second wave in Nigeria, there was a relaxation of lockdown imposed by the Federal and State Governments. As a result, Nigerians reverted to their everyday lives with minimal efforts to maintain the public health measures of hand and respiratory hygiene, use of face masks in public, and maintenance of physical distancing. Despite this behavior, the increase in the numbers of new infections was not pronounced, leading to the closure of isolation and treatment centers in Anambra State and several other States. Given these observations, the widespread occurrence of sub-clinical infection amongst many Anambra residents could not be ruled out; neither had it been established. This knowledge gap remains true for many parts of the country. Thus, in line with the WHO's proposal, the Anambra State Ministry of Health conducted a population seroprevalence survey for SARS-CoV-2 antibodies among Anambra State residents. As at 15 th November 2020, the State had tested a total of 7,552 samples from suspected cases and diagnosed 285 confirmed cases therefrom giving a positivity rate of 3 . 8%

(Anambra state ministry of health, 2020b). Healthcare worker infections accounted for 11 . 9%

(34/285) of all cases in the State. A total of 19 deaths were recorded, giving an overall case fatality rate of 6 . 7%, more than triple the national CFR, which was 1 . 8% (1,166/66,228) Nnewi North (Anambra state ministry of health, 2020c). There was a male to female ratio of 60:40 amongst the confirmed cases. Most cases were spread between the ages of 11-50 years, with the age group 11-40 years accounting for 61% (173/285) of the cases. The positivity trend, which tilted towards lower ages, could be due to the massive testing of school children -Fifty-two cases were diagnosed amongst children and young people aged between 10-20 years (18 . 2% of positive cases) (Anambra state ministry of health, 2020c).

The true extent of exposure to the SARS-CoV-2 virus to sub-populations within the State is crucial public health actions but remains unknown. Thus, a key objective of this study was to determine the proportion of the Anambra State population that had been infected by the SARS-CoV-2 virus and generated an antibody response. Secondarily was to investigate for socio-demographic factors associated with the exposure. 

This study is a population-based, age-stratified, one-time seroprevalence survey of all Anambra residents one year and above. This design is one of the three standard methods recommended by the WHO for SARS-CoV-2 population prevalence surveys (World Health Organization, 2020) . The logistical impediments to the iterative or prospective approaches made this design the preferred option for our context.

For ease of administration, the survey was based in health facilities (World Health Organization, 2020), and adopted a multi-stage sampling approach. In the first stage of the sampling process, all local government areas (LGA) in the State were selected for the survey.

For each LGA, a serialized list of all public and private health facilities with a monthly client load of at least 100 was obtained from the State Ministry of Health's Directorate for planning research and statistics. The health facilities' list formed the sampling frame for the second stage of the sampling process at the LGA level, from which five to thirteen facilities were selected by simple random sampling depending on the projected population of the LGA. In the third stage, fifteen eligible consenting participants were recruited consecutively from each of the selected health facilities . Out of this quota, two participants were to be healthcare staff whose duties involve routine close interactions with patients.

For the sample size calculation, each LGA was considered to have a sufficient population.

Given that the true population prevalence of the SARS-CoV-2 antibodies was unknown in our setting or similar, we assumed an anticipated prevalence of 50%. Alpha level was set at 5% and a power of 80% was desired. We inflated the initial estimate of the minimum sample size by a design effect of 1 . 5 to account for clustering along LGAs. The WHO recommended open-source software, OpenEpi.com (World Health Organization, 2020; Sullivan, Dean, Soe, 2009) , was utilized for the sample size calculation. Considering the impact of COVID-19-related infodemic (misinformation) in the State, as well as apprehension towards testing, we accounted for a possible rejection rate of up to 20%.

Using the State's population age structure, we computed the proportional sample fraction for each age group to ensure adequate age-representation.

For each selected health facility , all clients (≥ one year of age) and health staff were eligible for the survey. Clients and staff that declined consent were excluded from the study.

Consenting participants were serially recruited until the recruitment quota of 15 participants was reached. Trained healthcare workers used an adapted version of the WHO-recommended questionnaire (World Health Organization, 2020) to collect participant's relevant clinical and socio-demographic information (appendix 1). Where necessary, the information was explained in the predominant local language to enhance understanding. Data was collected on 21 symptoms of COVID-19 developed from symptoms listed in the WHO recommended survey tool and the state PHEOC symptom checklist. Also, each participant's pinprick blood sample was used for the SARS-CoV-2 antibodies Serological test. The survey started on the 8 th December 2020 and was concluded by 15 th December in all health facilities .

Two drops of whole blood from the finger prick of each participant's preferred hand were used for SARS-CoV-2 IgG and IgM antibodies testing with the Realy Tech SARS-CoV-2 Antibodies Rapid Test Device. The rapid test procedure followed the manufacturer's guidelines (Realy Tech Rapid Test Device, 2020). and the result read within 10 -15 minutes and recorded in the corresponding datasheet on the questionnaire. Each participant was assigned a two-digit code number written on the questionnaire and the test kit's ID space.

After testing and recording the result, a photograph of the test kit (showing the result section and participant's code) was taken and sent to the supervising team.

The Realy Check immunoassay kit used for the survey tested for the presence of SARS-CoV-2 IgG and IgM antibodies. A positive result could be for either, or both. Although we presented findings for each antibody, the crude and adjusted prevalence calculations were based on a dichotomized positive (IgG + IgM) or negative outcome. Simple frequencies were calculated as well as other descriptive statistics relevant to the sample. Chi-squared hypothesis tests were conducted to test association between exposure factors and categorical outcomes and significance value was set at 5%. Univariable and multivariable logistic regression analyses (using the simultaneous inclusion of variables) were carried out to clarify relationships between exposures and seropositivity. Crude and adjusted Odds ratios are presented with associated 95% confidence intervals estimated by means of the exact binomial method. Exposure variables that showed significant associations were included in the final multiple regression model. Analyses were carried out in IBM SPSS version 25. Using crude prevalence measures, we plot high-low-close charts, spatial dot maps (appendix 3), and sexdisaggregated population graphs of the positivity rates (appendix 3). Further details of the data analysis procedures are included in appendix 3.

The SARS-CoV-2 IgG and IgM rapid test kits utilized for the study were produced by Hangzhou Realy Tech Ltd and had reported sensitivity and specificity values determined in a pretest of 200 patients (Realy Tech Rapid Test Device, 2020). For SARS-CoV-2 specific IgG, a pre-determined sensitivity and specificity of 99% and 100% respectively was reported.

Similarly, for IgM, sensitivity and specificity were given as 98% and 99%, respectively. For our adjustment, we chose the lower test sensitivity of 98% and specificity of 99% for IgM.

We adjusted our crude prevalence measure to account for the rate of false positives that may have occurred as a result of the test kit used. Using the Bayesian conditional probability equation, we estimated the probability of actually having SARS-CoV-2 antibody given a positive test from the kits (Greenland, Robins, 1991) . Details in appendix 3.

The findings imply a 91 . 3% probability of having the SARS-CoV-2 antibody given that one tested positive using our test kits. We applied this probability to all our prevalence measures across the state and LGAs.

This study was funded by the Government of Anambra state through the COVID-19

intervention fund under the State Ministry of Health. The funding source had no role in determining the design of this study or the data collection and analyses plan. They played no role in the writing of this report as well as the decision to submit the manuscript for publication. All the authors had full access to the data from this study and bear the responsibility for the submission of this manuscript for publication.

On the whole, data from 3142 participants tested at the 210 participating health facilities across the 21

LGAs of the state were included in the analyses as summarized in table 1.

Although an initial 3150 persons were recruited at the sites, 6 declined while 2 entries lacked critical information on demographics and symptom screening and hence excluded from the analyses. 37 . 2% (1168) suggesting that they were infected with the SARS-CoV-2 infection months preceding the survey. Also, less than 10% of the participants were seropositive for IgM only, which should disappear after a few weeks of infection, suggesting a declining incidence of new SARS-CoV-2 infections in Anambra state before the second wave. This assumption is consistent with the COVID-19 situation in the State at the onset of the survey, including the closure of isolation/treatment centers.

The survey has further confirmed a higher urban prevalence of SARS-CoV-2 infections when compared to rural areas and other residential area sub-categories in the State. An earlier Ivorian survey found a significant association between city dwelling and seropositivity amongst mine workers from three different sites (Milleliri et al., 2021) .

Somewhat surprisingly, the seroprevalence among health workers did not differ from that of non-health workers. In similar settings, a crude seroprevalence of 45.1% was found amongst asymptomatic healthcare workers in Ibadan south west Nigeria (Olayanju et al., 2020) , 13 -36% from Congo Kinshasa, (Ndaye et al., 2021) and 20 . 8% from three different counties in Kenya (despite inter-county differences) (Etyang et al., 2021) Our finding could be a reflection of an early policy priority of the state to protect healthcare workers through provision of PPEs, strict enforcements of prevention measures, and training on infection prevention and control. It is also quite plausible that some 'non-healthcare' workers could have been at higher risk, these include petrol pump attendants, law enforcement agents, and public transport operators.

It was expected that participants that had social contacts with known COVID-19 patients would have significantly higher SARS-CoV-2 seroprevalence when compared with those without social contacts. On the contrary, the survey showed that the participants with unknown social contact history were significantly more likely to be SARS-CoV-2 seropositive when compared with those that reported social contacts with known COVID-19

patients. Furthermore, Anambra residents older than 39 seemed to have significantly higher odds of being infected with SARS-CoV-2 compared to the 10 -39 years age groups. This contrasts the child and adolescent predominance of the reported cases in the state since the large number of school children tested (using RT-PCR) prior to the resumption of schools skewed the age distribution of reported cases (Anambra state ministry of health, 2020c).

Interestingly, either the loss of sense of smell (anosmia) or taste (ageusia) predicted the SARS-CoV-2 infection among participants more than other symptoms. This is similar to earlier findings from other settings (Lan et al., 2020) . Therefore, it would be safer to rule out COVID-19 when any resident of the state presents with such symptoms. Furthermore, the survey confirms asymptomatic COVID-19 in Anambra State; about 24% of seropositive participants were without any of the COVID-19 symptoms defined by the WHO for the disease. Although the recall bias inherent with this study design is acknowledged, the true prevalence to reported cases ratio will likely be large (Murhekar, Clapan, 2021) .

In conclusion, the SARS-CoV-2 seroprevalence of 16 . 07% among residents of Anambra state confirms widespread community transmission of the disease in the State before the onset of the second wave in December 2020. The SARS-CoV-2 infection rate varied across age groups and was highest among residents above 49 years. Also, seroprevalence did not differ between males and females nor between health workers and non-health workers. The disease prevalence rate was higher among urban dwellers and amongst those who were uncertain of the COVID-19 disease status of their social contacts. In our environment, the clinical picture of COVID-19 shared key symptoms with some commonly occurring diseases such as Malaria and Tuberculosis but loss of smell and loss of taste were most predictive of seropositivity. A large proportion of the population remains highly susceptible to SARS-CoV-2 infection.

There is need to strengthen the enforcement of COVID-19 prevention messages and strategies to minimize community spread of the disease.

We acknowledge some limitations to this study. Resource limitations restricted us to the use of a rapid immunoassay test instead of ELISA test or a combination of the two tests; however, it has been shown that the two tests have comparable accuracy SAR-CoV-2 antibodies (Traugott et al., 2020) . We also relied on the manufacturer's reported sensitivity and specificity determined in a non-African population because our local validation of the test kits during the second wave of the COVID-19 showed similar findings (described in appendix 3). Furthermore, given that information on exposure and outcomes were obtained simultaneously, there was a possibility of information bias on account of recall especially as regards variables such as symptoms and contact history but, it was probably nondirectional and would not have affected the study outcomes substantially. Despite these drawbacks, the findings will help local public health efforts such as risk communication and resource allocation, as well as clinical symptom-based screening in our settings with limited access to RT-PCR.

The de-identified dataset from this survey can be made available upon reasonable request through a letter addressed to the honourable commissioner for health the Anambra State

Ministry of Health. The letter should detail the intended use of the data which will be verified by the department of research planning and statistics of the state ministry of health. Data will be released for purposes of research including meta-analyses. Requests should be sent to the email of the first author: vincentokpala@gmail.com or by post to the Anambra State Ministry of Health, Jerome Udoji Secretariat, Aroma Awka, Anambra, Nigeria.

This study was funded by the Anambra State Government through their COVID-19 intervention fund. We acknowledge the 210 health facility focal persons that conducted this survey in the selected health facilities, 21 LGA supervisors, 21 LGA focal persons, and the two data entry officers. We thank specially the participants for consenting to be part of this important research. The authors acknowledge the technical support from the World Health Organization field office in Awka. 

This study was funded by the Anambra State Government through their COVID-19 intervention fund.

In Nigeria, this intervention falls within the definition of Public health surveillance (in emergency response) nevertheless, ethical clearance was obtained from the Directorate of planning research and statistics of the Anambra state ministry of health. Before recruitment, each participant was counselled and informed verbal consent obtained. The counselling explained in clear terms the purpose of the survey, the voluntariness of participation, the potential risks, benefits to the individual and his/her community, as well as our commitment to maintaining confidentiality. To ensure anonymity, the LGAs, HFs, and participants were coded as appropriate -only these codes were written on participants' questionnaire/datasheet.

The consent form is attached as appendix 2. 

Lessons from co-production of evidence and policy in Nigeria's COVID-19 response

Anambra state strategic health development plan ii

Public health emergency operations center COVID-19 Situation Report

Public health emergency operations center COVID-19 Situation Report

Public health emergency operations center COVID-19 Situation Report

Brief History of Anambra State

Seroprevalence of Antibodies to SARS-CoV-2 among Health Care Workers in Kenya

Note from the editors: World Health Organization declares novel coronavirus (2019-nCoV) sixth public health emergency of international concern

Empirical-Bayes adjustments for multiple comparisons are sometimes useful

Seroprevalence of anti-SARS-CoV-2 IgG antibodies among truck drivers and assistants in Kenya. medRxiv

COVID-19 symptoms predictive of healthcare workers' SARS-CoV-2 PCR results

SARS-CoV-2 infection in Ivory Coast: a serosurveillance survey among goldmine workers

COVID-19 serosurveys for public health decision making. The Lancet Global Health

COVID-19 Outbreak in Nigeria Situation Report

COVID-19 Outbreak in Nigeria Situation Report. S/N 043

Challenges in interpreting SARS-CoV-2 serological results in African countries

Asymptomatic Frontline Health Workers in Ibadan, Nigeria. The American journal of tropical medicine and hygiene

On academics: OpenEpi: a web-based epidemiologic and statistical calculator for public health

Technical File for Realy Tech Rapid Test Device

Performance of Severe Acute Respiratory Comparison of Commercial Enzyme-Linked Immunosorbent Assays and Rapid Tests

Population-based age-stratified seroepidemiological investigation protocol for coronavirus 2019 (COVID-19) infection

What we know about the COVID-19 immune response: THE LATEST ON COVID-19 IMMUNITY & THE CURRENT GLOBAL SITUATION